| Title : A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients - Bent-Ennakhil_2017_Neurol.Ther_6_131 |
| Author(s) : Bent-Ennakhil N , Coste F , Xie L , Aigbogun MS , Wang Y , Kariburyo F , Hartry A , Baser O , Neumann P , Fillit H |
| Ref : Neurol Ther , 6 :131 , 2017 |
| Abstract : |
| PubMedSearch : Bent-Ennakhil_2017_Neurol.Ther_6_131 |
| PubMedID: 28508250 |
| Title : Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study - Lu_2005_Am.J.Geriatr.Pharmacother_3_92 |
| Author(s) : Lu S , Hill J , Fillit H |
| Ref : Am J Geriatr Pharmacother , 3 :92 , 2005 |
| Abstract : |
| PubMedSearch : Lu_2005_Am.J.Geriatr.Pharmacother_3_92 |
| PubMedID: 16129386 |
| Title : Economics of dementia and pharmacoeconomics of dementia therapy - Fillit_2005_Am.J.Geriatr.Pharmacother_3_39 |
| Author(s) : Fillit H , Hill J |
| Ref : Am J Geriatr Pharmacother , 3 :39 , 2005 |
| Abstract : |
| PubMedSearch : Fillit_2005_Am.J.Geriatr.Pharmacother_3_39 |
| PubMedID: 16089246 |
| Title : The economic benefits of acetylcholinesterase inhibitors for patients with Alzheimer disease and associated dementias - Fillit_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S24 |
| Author(s) : Fillit H , Hill J |
| Ref : Alzheimer Disease & Associated Disorders , 18 Suppl 1 :S24 , 2004 |
| Abstract : |
| PubMedSearch : Fillit_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S24 |
| PubMedID: 15249845 |
| Title : Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy - Fillit_2002_Fam.Med_34_528 |
| Author(s) : Fillit H , Hill JW , Fufferman R |
| Ref : Fam Med , 34 :528 , 2002 |
| Abstract : |
| PubMedSearch : Fillit_2002_Fam.Med_34_528 |
| PubMedID: 12144008 |
| Title : Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council - Fillit_2000_Manag.Care.Interface_13_51 |
| Author(s) : Fillit H , Cummings J |
| Ref : Manag Care Interface , 13 :51 , 2000 |
| Abstract : |
| PubMedSearch : Fillit_2000_Manag.Care.Interface_13_51 |
| PubMedID: 10747691 |
| Title : Donepezil use in managed Medicare: effect on health care costs and utilization - Fillit_1999_Clin.Ther_21_2173 |
| Author(s) : Fillit H , Gutterman EM , Lewis B |
| Ref : Clin Ther , 21 :2173 , 1999 |
| Abstract : |
| PubMedSearch : Fillit_1999_Clin.Ther_21_2173 |
| PubMedID: 10645761 |
| Title : Opportunities for improving managed care for individuals with dementia: Part 1--The issues - Fillit_1999_Am.J.Manag.Care_5_309 |
| Author(s) : Fillit H , Knopman D , Cummings J , Appel F |
| Ref : Am J Manag Care , 5 :309 , 1999 |
| Abstract : |
| PubMedSearch : Fillit_1999_Am.J.Manag.Care_5_309 |
| PubMedID: 10351027 |